Current Clinical Trials at Neuroscience Group
Our office is currently participating in the Multiple Sclerosis clinical research trials/programs listed below. If you would like more information about any of these programs, speak with your provider to see if you may qualify for a current study or call our Clinical Research Coordinator at 920-725-9373 Ext. 1015 for more information.
PASSAGE: A world-wide study in patients who are starting new treatment for relapsing forms of multiple sclerosis (MS). Your participation in the study will provide an opportunity to learn more about the safety and satisfaction of MS treatments.
ESTEEM: A multicenter, global, observational study to collect information on safety and to document the drug utilization of Tecfidera™ (Dimethyl Fumarate) when used in routine medical practice in the treatment of multiple sclerosis (ESTEEM).
ASCLEPIOS: A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis.
Frequently Asked Questions
How can I participate in a clinical trial?
Speak with your provider to see if you may qualify for a current study or call our Clinical Research Coordinator at 920-725-9373 x 1015 for more information.
Are clinical trials safe?
The FDA works to protect participants in clinical trials and ensure that people have reliable information as they decide whether to join a clinical trial. The federal government has regulations and guidelines for clinical research to protect participants from unreasonable risks. Although efforts are made to control the risks to clinical trial participants, some risks may be unavoidable because of the uncertainty inherent in medical research studies involving new medical treatments.
What should I think about before joining a clinical trial?
People should learn as much as possible about the clinical trials that interest them. They should also feel comfortable discussing their questions and concerns with member of their health care team. Prospective participants should understand what happens during the trial, the type of health care they will receive and any costs to them—which may or may not include the cost of the product and costs associated with administering the product.